The bradykinin-degrading aminopeptidase P is increased in women taking the oral contraceptive pill

A. L C La Corte, Angela M. Carter, Anthony J. Turner, Peter J. Grant, Nigel M. Hooper

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Introduction. The renin-angiotensin and kininogen-kinin hormonal systems are critically involved in regulating blood pressure and are candidates in contributing to oral contraceptive pill (OCP)-induced hypertension.Angiotensin-converting enzyme (ACE) and aminopeptidase P (AP-P) are key enzymes in these systems and are both involved in the degradation of the vasodilator bradykinin. Methods. Circulating ACE and AP-P levels were measured by activity assay using selective fluorogenic peptide substrates in plasma samples from the Leeds Family Study. In addition, the effect of progesterone on the expression of AP-P and ACE was examined in cells. Results. Women on the OCP had higher age-adjusted plasma AP-P (mean [95% confidence interval]) (0.27 [0.23-0.32] nmol/min/ml (n = 53)) compared with women not on the OCP (0.17 [0.16-0.19] nmol/min/ml (n = 133), p <0.001) or males (0.19 [0.17-0.20] nmol/min/ml (n = 209), p
    Original languageEnglish
    Pages (from-to)221-225
    Number of pages4
    JournalJRAAS - Journal of the Renin-Angiotensin-Aldosterone System
    Volume9
    Issue number4
    DOIs
    Publication statusPublished - 2008

    Keywords

    • Aminopeptidase
    • Blood pressure
    • Oral contraceptive pill

    Research Beacons, Institutes and Platforms

    • Dementia@Manchester

    Fingerprint

    Dive into the research topics of 'The bradykinin-degrading aminopeptidase P is increased in women taking the oral contraceptive pill'. Together they form a unique fingerprint.

    Cite this